Risk factors for candidemia: a prospective matched case-control study
Open Access
- 18 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 24 (1), 1-11
- https://doi.org/10.1186/s13054-020-2766-1
Abstract
Candidemia is an opportunistic infection associated with high morbidity and mortality in patients hospitalized both inside and outside intensive care units (ICUs). Identification of patients at risk is crucial to ensure prompt antifungal therapy. We sought to assess risk factors for candidemia and death, both outside and inside ICUs. This prospective multicenter matched case-control study involved six teaching hospitals in Switzerland and France. Cases were defined by positive blood cultures for Candida sp. Controls were matched to cases using the following criteria: age, hospitalization ward, hospitalization duration, and, when applicable, type of surgery. One to three controls were enrolled by case. Risk factors were analyzed by univariate and multivariate conditional regression models, as a basis for a new scoring system to predict candidemia. One hundred ninety-two candidemic patients and 411 matched controls were included. Forty-four percent of included patients were hospitalized in ICUs, and 56% were hospitalized outside ICUs. Independent risk factors for candidemia in the ICU population included total parenteral nutrition, acute kidney injury, heart disease, prior septic shock, and exposure to aminoglycoside antibiotics. Independent risk factors for candidemia in the non-ICU population included central venous catheter, total parenteral nutrition, and exposure to glycopeptides and nitroimidazoles. The accuracy of the scores based on these risk factors is better in the ICU than in the non-ICU population. Independent risk factors for death in candidemic patients included septic shock, acute kidney injury, and the number of antibiotics to which patients were exposed before candidemia. While this study shows a role for known and novel risk factors for candidemia, it specifically highlights important differences in their distribution according to the hospital setting (ICU versus non-ICU). This study provides novel risk scores for candidemia accounting for the hospital setting and recent progress in patients’ management strategies and fungal epidemiology.Keywords
Funding Information
- Swiss National Foundation (324730-144054 and 33IC30_179636)
- European Union’s Seventh Framework Program (HEALTH-2010–260338)
This publication has 49 references indexed in Scilit:
- Estimating the Receiver Operating Characteristic Curve in Studies That Match Controls to Cases on CovariatesAcademic Radiology, 2013
- Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011Journal of Clinical Microbiology, 2012
- Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study*Critical Care Medicine, 2011
- National Surveillance of Fungemia in Denmark (2004 to 2009)Journal of Clinical Microbiology, 2011
- Bench-to-bedside review: Therapeutic management of invasive candidiasis in the intensive care unitCritical Care, 2010
- Reproducible Community Dynamics of the Gastrointestinal Microbiota following Antibiotic PerturbationInfection and Immunity, 2009
- Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care settingEuropean Journal of Clinical Microbiology & Infectious Diseases, 2007
- A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization*Critical Care Medicine, 2006
- Levofloxacin and Moxifloxacin Increase Human Gut Colonization by Candida SpeciesAntimicrobial Agents and Chemotherapy, 2005
- Candida Colonization and Subsequent Infections in Critically III Surgical PatientsAnnals of Surgery, 1994